These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 8093146

  • 1. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation.
    Papadopoulos EB, Ladanyi M, Emanuel D, Mackinnon S, Boulad F, Carabasi MH, Castro-Malaspina H, Childs BH, Gillio AP, Small TN.
    N Engl J Med; 1994 Apr 28; 330(17):1185-91. PubMed ID: 8093146
    [Abstract] [Full Text] [Related]

  • 2. Unsuccessful CTL transfusion in a case of post-BMT Epstein-Barr virus-associated lymphoproliferative disorder (EBV-LPD).
    Imashuku S, Goto T, Matsumura T, Naya M, Yamori M, Hojo M, Hibi S, Todo S.
    Bone Marrow Transplant; 1997 Aug 28; 20(4):337-40. PubMed ID: 9285550
    [Abstract] [Full Text] [Related]

  • 3. Adoptive cell therapy with donor lymphocytes for EBV-associated lymphomas developing after allogeneic marrow transplants.
    O'Reilly RJ, Lacerda JF, Lucas KG, Rosenfield NS, Small TN, Papadopoulos EB.
    Important Adv Oncol; 1996 Aug 28; ():149-66. PubMed ID: 8791134
    [No Abstract] [Full Text] [Related]

  • 4. Lymphocytosis of donor origin in cerebrospinal fluid, and marrow aplasia after donor leukocyte infusion for EBV-lymphoproliferative disease.
    Gharpure V, Rubin L, Amlin J, Emanuel D, Schroeder W, Davidson A, Hromas R, Cornetta K.
    Bone Marrow Transplant; 1996 Jul 28; 18(1):221-4. PubMed ID: 8832021
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease.
    Okamura T, Kishimoto T, Inoue M, Honda M, Yamashita N, Wakiguchi H, Yagita M, Hosoi G, Sako M, Yasui M, Yagi K, Kawa K.
    Bone Marrow Transplant; 2003 Jan 28; 31(2):105-11. PubMed ID: 12621491
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disorder simultaneously affecting both B and T cells after allogeneic bone marrow transplantation.
    Chuhjo T, Yachie A, Kanegane H, Kimura H, Shiobara S, Nakao S.
    Am J Hematol; 2003 Apr 28; 72(4):255-8. PubMed ID: 12666136
    [Abstract] [Full Text] [Related]

  • 9. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.
    Hanto DW, Frizzera G, Purtilo DT, Sakamoto K, Sullivan JL, Saemundsen AK, Klein G, Simmons RL, Najarian JS.
    Cancer Res; 1981 Nov 28; 41(11 Pt 1):4253-61. PubMed ID: 6272971
    [Abstract] [Full Text] [Related]

  • 10. Post-transplantation lymphoproliferative disorders in Mexico: an aggressive clonal disease associated with Epstein-Barr virus type A.
    Quintanilla-Martínez L, Lome-Maldonado C, Schwarzmann F, Gredler E, Reyes E, Angeles-Angeles A, Fend F.
    Mod Pathol; 1998 Feb 28; 11(2):200-8. PubMed ID: 9504692
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: report of two cases.
    Hauke RJ, Greiner TC, Smir BN, Vose JM, Tarantolo SR, Bashir RM, Bierman PJ.
    Bone Marrow Transplant; 1998 Jun 28; 21(12):1271-4. PubMed ID: 9674863
    [Abstract] [Full Text] [Related]

  • 12. Posttransplant lymphoproliferative disorder in pediatric bone marrow transplant recipients: disseminated disease of donor origin demonstrated by fluorescence in situ hybridization.
    Lones MA, Lopez-Terrada D, Shintaku IP, Rosenthal J, Said JW.
    Arch Pathol Lab Med; 1998 Aug 28; 122(8):708-14. PubMed ID: 9701332
    [Abstract] [Full Text] [Related]

  • 13. Simian virus 40 in posttransplant lymphoproliferative disorders.
    Vilchez RA, Jauregui MP, Hsi ED, Novoa-Takara L, Chang CC.
    Hum Pathol; 2006 Sep 28; 37(9):1130-6. PubMed ID: 16938517
    [Abstract] [Full Text] [Related]

  • 14. Adoptive immunotherapy with allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T-lymphocytes for recurrent, EBV-positive Hodgkin disease.
    Lucas KG, Salzman D, Garcia A, Sun Q.
    Cancer; 2004 May 01; 100(9):1892-901. PubMed ID: 15112270
    [Abstract] [Full Text] [Related]

  • 15. Late onset Epstein-Barr virus-associated lymphoproliferative disease after allogeneic bone marrow transplant presenting as breast masses.
    Abhyankar SH, Chiang KY, McGuirk JP, Pati AR, Godder KT, Welsh JA, Waldron RL, McElveen JL, Henslee-Downey PJ.
    Bone Marrow Transplant; 1998 Feb 01; 21(3):295-7. PubMed ID: 9489654
    [Abstract] [Full Text] [Related]

  • 16. Using T cells to treat B-cell cancers.
    Lieberman J, Buchsbaum RJ.
    N Engl J Med; 1994 Apr 28; 330(17):1231-3. PubMed ID: 8139635
    [No Abstract] [Full Text] [Related]

  • 17. Adoptive immunotherapy using donor leukocytes following bone marrow transplantation for chronic myeloid leukemia: is T cell dose important in determining biological response?
    Mackinnon S, Papadopoulos EB, Carabasi MH, Reich L, Collins NH, O'Reilly RJ.
    Bone Marrow Transplant; 1995 Apr 28; 15(4):591-4. PubMed ID: 7655386
    [Abstract] [Full Text] [Related]

  • 18. Correction of DiGeorge anomaly with EBV-induced lymphoma by transplantation of organ-cultured thymus and Epstein-Barr-specific cytotoxic T lymphocytes.
    Hong R, Shen V, Rooney C, Hughes DP, Smith C, Comoli P, Zhang L.
    Clin Immunol; 2001 Jan 28; 98(1):54-61. PubMed ID: 11141327
    [Abstract] [Full Text] [Related]

  • 19. Epstein-Barr virus-associated B-cell proliferations of diverse clonal origins after bone marrow transplantation in a 12-year-old patient with severe combined immunodeficiency.
    Shearer WT, Ritz J, Finegold MJ, Guerra IC, Rosenblatt HM, Lewis DE, Pollack MS, Taber LH, Sumaya CV, Grumet FC.
    N Engl J Med; 1985 May 02; 312(18):1151-9. PubMed ID: 2984567
    [Abstract] [Full Text] [Related]

  • 20. Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells.
    Verdonck LF, Petersen EJ, Lokhorst HM, Nieuwenhuis HK, Dekker AW, Tilanus MG, de Weger RA.
    Bone Marrow Transplant; 1998 Dec 02; 22(11):1057-63. PubMed ID: 9877267
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.